Medopad Transforms Deep Vein Disease Treatments
Guy’s and St Thomas’ NHS Foundation Trust is the latest hospital to use Medopad’s Patient Monitoring to help treat patients with venous diseases.
The hospital’s highly specialised vascular team, one of the world’s most respected clinics for deep vein disease management and research, is pioneering the use of Medopad.
The two diseases in question are Post-Thrombotic Syndrome (PTS, which is caused by Deep Vein Thrombosis), and Chronic Venous Insufficiency CVI) – a long-term condition that develops independently of DVT.
Both diseases are incurable and patients are supported by a dedicated multi-disciplinary care team.
The symptoms Medopad’s mobile solution monitors in real-time include pain levels, itching, swelling, varicose veins and in severe cases, ulceration. This data is securely shared with the care team, providing a vital real-time link between both clinicians and patients.
Patients also undergo multiple treatments depending on the severity of their condition - options involve compression stockings or in more developed cases, endovascular procedures and newer surgical reconstruction procedures. Medopad Patient Monitoring is now part of these treatment and recovery plans.
Read about our latest news and achievements.
The Leg Ulcer Charity and Medopad have launched a new mobile application for patients and their carers across the UK. In its first phase, the app will be available for 25,000 patients, before rolling out to over 500,000 people.Read More
Medopad Wins Funding to Tackle Diabetes in Singapore through the Singapore QuickFire Challenge – Metabolic Disease Innovation
Medopad Wins Funding to Tackle Diabetes in Singapore through the Singapore QuickFire Challenge – Metabolic Disease InnovationRead More
and many more...